The co-administration of desloratadine with erythromycin, azithromycin, ketoconazole, fluoxetine or cimetidine resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but no clinically relevant changes in the safety profile of desloratadine were observed.